Ki
King Faisal Spec Hosp
NPRiyadh SAFounded 197510,000 employees
Private CapacadPrivateOncologyHematology
Platform: Tertiary Care
Market Cap
N/A
All Drugs
7
Clinical Trials
7
Failed / Terminated
2
FDA Approved
2
Drug Pipeline (7 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KIN-IIT-300 | KIN-IIT-300 | Phase 2/3 | 1 | PARP | Pompe | ||
| KIN-IIT-616 | KIN-IIT-616 | Phase 2 | 1 | LAG-3 | Pancreatic Ca | ||
| KIN-IIT-683 | KIN-IIT-683 | Phase 2 | 1 | TYK2 | MCC | ||
| KIN-IIT-636 | KIN-IIT-636 | Phase 3 | 1 | KRASG12D | Endometrial Ca | ||
| KIN-IIT-556 | KIN-IIT-556 | Approved | 1 | CD20 | Pompe | ||
| KIN-IIT-763 | KIN-IIT-763 | Phase 1/2 | 1 | JAK1 | RA | ||
| KIN-IIT-791 | KIN-IIT-791 | Approved | 1 | TNFα | Breast Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)